A phase III study on the efficacy and safety of docetaxel, every three weeks or as a weekly regimen in patients with metastatic breast cancer

Pax H.B. Willemse,Linda de Munck, G. J. Creemers, H. Graaf,W. Smit,Z. Erjavec,J. M. Stouthard,G. Deijk,A. Bochove, W. Vader, A. M. Westermonn

BREAST CANCER RESEARCH AND TREATMENT(2007)

Cited 23|Views16
No score
Key words
metastatic breast cancer,docetaxel,breast cancer,weekly regimen,efficacy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined